Adapsyn Bioscience Inc.

6 records totalling $1,256,473.00 CAD, from official Government of Canada open data.

Embed this chart

By department

Records

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2020-2021
Canada

Adapsyn’s proprietary drug discovery platform will be applied to the screening of bacteria to discover neuro- and immunomodulatory small molecules to develop therapeutic agents for the treatment of ch...

Federal Economic Development Agency for Southern Ontario | Agence fédérale de développement économique pour le Sud de l'Ontario
Regional Relief and Recovery Fund (RRRF) – Direct
FY 2019-2020
Canada

RRRF funding will be used to support Recipients to address the impacts of the COVID-19 pandemic.

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
FY 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
FY 2020-2021
Canada

The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2018-2019
Canada

Bacterial strains from the human microbiome will be screened for the production of secondary metabolites with the potential to influence the human nervous and immune systems, for potential application...

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
FY 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.